MustGrow Biologics Corp. has seen mixed performance recently, with a notable earnings call shedding light on its financial health.
This week, MustGrow Biologics Corp. (MGRO.V) experienced a slight decline of 1.20% in its stock price, closing at C$0.43. Despite this minor setback, the company has maintained steady performance over the past week, with no significant fluctuations. Investors are closely watching the recent earnings call, which provided insights into the company's financial trajectory.
Investor takeaway: MustGrow Biologics Corp. continues to navigate a challenging market environment, with its recent earnings call highlighting both achievements and ongoing challenges. Investors should consider the implications of the company's performance metrics and analyst outlook as they assess potential future movements in the stock.
Advertisement
MustGrow Biologics Corp.
MGRO.V
MGRO.V
MustGrow Biologics Corp.
WealthAwesomeMarket cap
$28.16M
52W high
$0.94
52W low
$0.29
1W change
-4.76%
Beta
0.56
Analyst Price Targets
Based on analyst covering MGRO · as of Sep 30, 2026
Wall Street analysts forecast MGRO stock price to rise 527.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.51
+527.5% Upside
Previously C$2.70 on Sep 17, 2026
Current Price
C$0.40
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MGRO's historical volatility
30-Day Vol
73.9%
Annualized
90-Day Vol
79.9%
Annualized
Trend (90d)
+10.6%
Annualized drift
90d Mean
C$0.42
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.41 | C$0.31 – C$0.52 |
| 60 trading days | C$0.41 | C$0.29 – C$0.59 |
| 90 trading days | C$0.42 | C$0.27 – C$0.65 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
C$0.43 Closing Price Reflects 1D Decline of 1.20%
Advertisement
With a market cap of C$28.86 million and a 52-week trading range of C$0.29 to C$0.94, MustGrow Biologics Corp. is currently trading at 22% of its range, indicating potential volatility ahead.
Bull case
The recent earnings call indicated that MustGrow has achieved a net profit, which could signal a turnaround in its financial performance. Analysts have set an average target of C$2.70, suggesting a significant upside for investors and indicating that the market may be undervaluing the company's potential.
Bear case
Despite the optimistic outlook from analysts, MustGrow's current financial metrics raise concerns. The company has a high profit margin loss of 58.5% and a return on equity of -222.5%, reflecting ongoing operational challenges. Additionally, the stock has underperformed significantly year-to-date, down 34.92%, which could make investors hesitant.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
